Harmless lung cancer? A provocative study found that nearly 1 in 5 lung tumors detected on CT scans are probably so slow-growing that they would never cause problems. The analysis suggests the world's No. 1 cause of cancer deaths isn't as lethal as doctors once thought.
Princeton University has begun vaccinating nearly 6,000 students to try to stop an outbreak of type B meningitis in an unusual federal government-endorsed administration of a drug not generally approved for use in the United States.
Boehringer Ingelheim has scored a perfect 100 in the Human Rights Campaign (HRC) Foundation’s Corporate Equality Index. The yearly report from the HRC ranks companies according to their compliance with LGBT practices and policies.
Accelrys, a provider of scientific innovation lifecycle management solutions, has acquired Ireland-based QUMAS, a global provider of Cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations in life sciences and other highly regulated industries.
Merck has provided an update on the development program for MK-8931, a novel investigational oral β-amyloid precursor protein site-cleaving enzyme (BACE) inhibitor.
To provide more clarity and transparency regarding its projections for 2014, given the significant uncertainty concerning possible generic competition to Copaxone ® in the U.S., Teva is providing two alternative scenarios for its current non-GAAP financial outlook for the year.
Navidea Biopharmaceuticals announced today that the FDA has granted Fast Track designation to Lymphoseek® (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer.
The United States and 11 other nations negotiating a free trade zone stretching from Chile to Japan failed to reach a final agreement at talks in Singapore, but indicated they were closing in on a landmark deal.
Shares of Acura Pharmaceuticals Inc. rose Monday after the company said it met with federal regulators to discuss a new version of the painkiller hydrocodone that uses the company's abuse-resistant technology. Acura said the meeting with the Food and Drug Administration focused on a mid-stage study of a mixture of hydrocodone and acetaminophen that is designed to be harder to abuse.
The Vic-Press™ Series P569 and Series P589 ball valves are designed to be used with the Vic-Press system, a flame-free press-to-connect system that joins pipe, valves and fittings in a matter of seconds.
The SetLine Wrap-Around Packer is a multi-functional, end-of-line packaging system that enables a wide variety of packaging solutions for a variety of products.
Charles River Laboratories today announced organizational changes which are designed to continue to improve the company’s operating efficiency across its global portfolio and enhance its ability to meet the needs of its clients. These changes represent the next step in Charles River’s continuing effort to position the Company as the partner of choice for early-stage drug development and to drive future growth.
Forest Laboratories, Inc. today announced appointments to its executive leadership team. The appointments are part of Forest’s announced plans to flatten and broaden the organization as part of Project Rejuvenate.
A new poll that shows young voters are increasingly disenchanted with the president and his signature health-care law.
NASA and the Center for the Advancement of Science in Space (CASIS) are enabling research aboard the International Space Station that could lead to new stem cell-based therapies for medical conditions faced on Earth and in space.Scientists will take advantage of the space station's microgravity environment to study the properties of non-embryonic stem cells.